Experimental groups | Duration (month) | Dose (mg/L) | Body weight gain (g) | Splenic weight (g) | T-As in spleen (ng/g) |
---|---|---|---|---|---|
Group 1 | 1 | 0 | 11.64 ± 1.83 | 0.11 ± 0.03 | < LD |
Group 2 | 1 | 25 | 11.98 ± 1.74 | 0.10 ± 0.03 | 31.46 ± 9.18 |
Group 3 | 1 | 50 | 11.76 ± 2.30 | 0.10 ± 0.02 | 39.95 ± 3.86 |
Group 4 | 3 | 0 | 19.61 ± 1.95 | 0.10 ± 0.03 | < LD |
Group 5 | 3 | 25 | 18.57 ± 3.86 | 0.10 ± 0.02 | 38.31 ± 5.87 |
Group 6 | 3 | 50 | 18.41 ± 1.27 | 0.10 ± 0.02 | 36.34 ± 19.82 |
Group 7 | 12 | 0 | 24.51 ± 3.59 | 0.10 ± 0.02 | < LD |
Group 8 | 12 | 25 | 23.21 ± 4.78 | 0.11 ± 0.02 | 47.80 ± 15.90 |
Group 9 | 12 | 50 | 24.80 ± 2.11 | 0.10 ± 0.03 | 52.42 ± 3.29 |